Ultraviolet (UV) irradiation of
HtrA2, which antagonize the caspase-inhibitory IAP proteins, and AIF and EndoG, which cause apoptotic changes independent of caspase activity (Susin et al. 1999; Du et al. 2000; Verhagen et al. 2000; Li et al. 2001; Suzuki et al. 2001; Hegde et al. 2002; Martins et al. 2002) .
The balance between pro-and antiapoptotic Bcl-2 family members determines the mitochondrial response to apoptotic stimuli (Gross et al. 1999; Martinou and Green 2001) . Antiapoptotic proteins such as Bcl-2, Bcl-x L , and Mcl-1 protect mitochondrial integrity, whereas the proapoptotic members of the family promote the release of apoptogenic proteins from mitochondria. The function of these proapoptotic proteins can be further divided into the BH3-only proteins including Bid, Bad, and Bim and their effectors Bak and Bax Wei et al. 2001; Zong et al. 2001) . Activated BH3-only proteins induce the formation of mitochondrial oligomeric Bax/Bak complexes either directly or indirectly by binding and inactivating antiapoptotic Bcl-2 family members Letai et al. 2002) . These complexes may function as protein pores for cytochrome c and other proteins to pass through, or cause mitochondrial outer membrane destabilization (Vander Heiden et al. 1997; Kuwana et al. 2002) .
The essential question of how the Bcl-2 family of proteins translates genotoxic stress into mitochondrial damage remains unaddressed. In the present report, we used classic biochemical fractionation and reconstitution to map a sequential signaling pathway composed of Bcl-2 family members that leads to cytochrome c release after UV treatment.
Results

Activation of a mitochondrial apoptotic pathway in response to UV irradiation
After receiving a strong dose of UV irradiation, cultured HeLa cells exhibit synchronized characteristic apoptotic changes beginning 2 h after irradiation. After 4 h, most cells die by apoptosis. As shown in Figure 1A (lanes 1-4), these changes include the oligomerization of Bak, the appearance of cytochrome c in the cytosol, and the activation of caspase-9 and caspase-2.
When cells were irradiated in the presence of a pancaspase inhibitor, z-VAD-fmk, caspase-9 activation was completely blocked (Fig. 1A, . However, the oligomerization of Bak and release of cytochrome c remained intact, indicating that these two events are upstream of caspase activation. Caspase-2 activation was also blocked by zVAD-fmk, suggesting that caspase-2 activation is not required for UV-induced cytochrome c release in HeLa cells as it is in oncogene transformed human fibroblasts (Lassus et al. 2002) .
The mitochondria from UV-irradiated cells were primed to release cytochrome c in vitro
In vivo, mitochondria from UV-irradiated cells start to release cytochrome c 120 min after UV irradiation; however, mitochondria isolated from cells just 30-60 min after UV irradiation readily formed oligomerized Bak and released cytochrome c when incubated in vitro (Fig. 1B,  lanes 2-3) . In contrast, mitochondria from untreated cells did not form oligomerized Bak or release cytochrome c under the same conditions (Fig. 1B, lane 1) . Mitochondria from cells 30-60 min after UV are therefore "primed" to release cytochrome c in vitro, at least 1 h before cytochrome c release can be detected in vivo.
Inhibitors in normal cytosol prevent cytochrome c release from primed mitochondria
Our finding that cytochrome c release is delayed in vivo compared with in vitro is consistent with a previous report predicting that cytoplasm contains inhibitors of cy- Figure 1 . UV induces cytochrome c release from HeLa cells in vivo and in vitro. (A) Mitochondria and S100 were harvested from HeLa cells treated with UV for different amounts of time as described in Materials and Methods. In lanes 5-8, we preincubated the cells in the presence of Z-VAD.fmk, a broad-spectrum caspase inhibitor as indicated. Cytochrome c, caspase-9, and caspase-2 were analyzed in S100. Bak oligomerization was analyzed in mitochondrial fractions as described . (B) Mitochondria from UV-treated cells release cytochrome c in vitro. Mitochondria (0.67 mg/mL) from untreated cells (lane 1) or cells that were UV-treated for 30 min (lane 2), 60 min (lane 3), or 120 min (lane 4) were incubated in vitro at 37°C for 30 min. Following incubation, the mitochondria were pelleted and analyzed as described in Materials and Methods. (C) S100 inhibits cytochrome c release from primed mitochondria. Mitochondria (0.67 mg/mL) from cells treated with UV for 1 h were coincubated (lanes 1-5) at 37°C for 30 min with only buffer (lane 1) or HeLa S100 (4 mg/mL) from untreated cells (lane 2) or cells that were UV-treated for 30 min (lane 3), 60 min (lane 4), or 120 min (lane 5). Mitochondria and supernatants were analyzed for Bak oligomerization and cytochrome c release, respectively. tochrome c release (Duelli and Lazebnik 2000) . To test this hypothesis in our system, primed mitochondria isolated from cells 60 min after UV irradiation were incubated with cytosol (S100) from untreated cells (naive), or cells 30-120 min after UV irradiation. As shown in Figure 1C , cytosol from naive cells efficiently inhibited cytochrome c release from UV-primed mitochondria (Fig.  1C, lane 2) . The ability of cytosol to inhibit release was gradually lost with increasing time after UV irradiation (Fig. 1C, lanes 3-5) .
Purification and identification of Mcl-1 and Bcl-x L as the cytosolic inhibitors of cytochrome c release
We used biochemical fractionation in concert with a candidate protein approach to identify the inhibitors present in the cytosol of naive cells. The cytosol from naive HeLa cells was fractionated by ammonium sulfate precipitation, ion exchange Mono Q column chromatography, gel-filtration column chromatography (data not shown), and hydroxyapatite chromatography (data not shown), and assayed for inhibition of cytochrome c release from UV-primed mitochondria. As shown in the upper panel of Figure 2A , 30% ammonium sulfate precipitated the activity ( Fig. 2A, lanes 4,6) . The precipitated activity was subsequently loaded onto a Mono Q column, and an activity peak was eluted from the column by ∼200 mM NaCl (Fig. 2B, upper panel, lane 9) .
Because antiapoptotic members of the Bcl-2 family of proteins are likely candidates for such an activity, we probed the column fractions using antibodies against these proteins. As shown in the middle and lower panels of Figure 2A and B, we found that Bcl-x L and Mcl-1 copurified with the inhibitory activity. Mcl-1 and Bcl-x L correlate with inhibitory activity after ammonium sulfate fractionation. Ammonium sulfate was added to 1 mL of S100 (5 mg/mL) up to 30% (lanes 3,4) or 50% (lanes 5,6) . Following incubation at 4°C for 1 h, the supernatant (Sup) and pellet (Pel) were separated by centrifugation (20,000g). The pellet was resuspended in 1 mL of Buffer A. Both the supernatants and pellets were dialyzed in Buffer A overnight. All fractions were assayed for inhibitory activity (as described in Materials and Methods) and evaluated for Mcl-1 and Bcl-x L . (B) HeLa S100 (36 mg) was first precipitated with 30% ammonium sulfate. The resulting pellet (7.5 mg) was resuspended and dialyzed in Buffer A and then loaded onto a 1-mL Hi-trap Q Sepharose column (Amersham) equilibrated in Buffer A. The protein was eluted with a gradient from 0 to 750 mM NaCl (in Buffer A) over 14 mL. Inhibitory activity was assayed for buffer alone (lane 1), input (lane 2), Q flow through (lane 3), and fractions eluting from Q sepharose (lanes 4-13) . The amount of Mcl-1 and Bcl-x L in each sample and the mitochondria (lane 1) was measured by Western blot. (C) HeLa S100 was immunodepleted as described in Materials and Methods. Inhibitory activity was assayed in buffer alone (lane 1), S100 mock-immunodepleted (lane 2), depleted of Mcl-1 (lane 3), Bcl-x L (lane 4), or both (lane 5). The amount of Mcl-1 and Bcl-x L was determined by Western blot for each S100 sample. (D) Recombinant Mcl-1 (rMcl-1) and Bcl-x L (rBcl-x L ) were prepared as described in Materials and Methods. S100, rMcl-1, and rBcl-x L were analyzed for inhibitory activity. The levels of Mcl-1 and Bcl-x L in recombinant fractions were compared with those in S100. Mitochondria solubilized in Buffer A with 1% NP-40 were analyzed for Mcl-1 and Bcl-x L to compare the levels of these proteins in mitochondria to those in the fractions.
We tested whether the inhibitory activity in naive cytosol was due to Mcl-1 and Bcl-x L by immunodepleting these two proteins either individually or in combination from naive S100. As shown in the middle and lower panels of Figure 2C , antibodies against Mcl-1 and Bcl-x L efficiently depleted these proteins from naive cytosol (Fig.  2C, lanes 3-5) . Cytosol depleted of Mcl-1 (Fig. 2C, lane 3) or Bcl-x L (Fig. 2C , lane 4) lost some activity whereas cytosol depleted of both (Fig. 2C, lane 5) completely lost the ability to inhibit cytochrome c release, indicating that both Mcl-1 and Bcl-x L are necessary for full activity (Fig. 2C, upper panel) .
To confirm that Bcl-x L and Mcl-1 are sufficient to inhibit cytochrome c release from UV-treated mitochondria, purified recombinant Bcl-x L or Mcl-1 was incubated with UV-primed mitochondria. As shown in the upper panel of Figure 2D , 3 nM Mcl-1 or 10 nM Bcl-x L was able to completely block cytochrome c when added directly to UV-primed mitochondria ( 
UV irradiation triggers a decrease in Mcl-1 levels and the translocation of Bcl-x L to the mitochondria
The inhibition of cytochrome c release in naive cytosol is removed by UV irradiation (Fig. 1C , lanes 3-5). We therefore examined the levels of Mcl-1 and Bcl-x L in cytosol and mitochondria isolated from naive and UVtreated cells. As shown in Figure 3A , the total amount of Mcl-1 was markedly decreased 1 h after UV treatment and completely disappeared after 2 h (Fig. 3A, lanes 1-4) . On the other hand, the total amount of Bcl-x L in cells did not change even 4 h after UV irradiation. However, cytosolic Bcl-x L started to decrease 1 h after UV irradiation and disappeared by 4 h, when robust apoptosis is observed (Fig. 3A , middle panel, lanes 5-8). Unlike Mcl-1, there was a corresponding increase of Bcl-x L on mitochondria, indicating that Bcl-x L translocates from cytosol to mitochondria after UV irradiation (Fig. 3A , middle panel, lanes 9-12). As a loading control, the levels of cytochrome c oxidase, a mitochondrial inner membrane protein, and a cross-reactive cytosolic protein remained unchanged (Fig. 3A, lower panel) . The translocation of Bcl-x L from the cytosol to the mitochondria was previously described in thymocytes undergoing apoptosis (Hsu et al. 1997) . In that study, the authors also showed that Bax, a proapoptotic Bcl-2 family member, similarly translocated from the cytosol to the mitochondria. Bax translocation, along with cytochrome c release and caspase activation, is commonly used as a marker for apoptosis.
To test whether the disappearance of Mcl-1 and translocation of Bcl-x L is specific to HeLa cells, we treated human fibroblasts with UV and tracked the levels of with UV for different amounts of time were either harvested for 1% CHAPS total cell lysate or fractionated into mitochondria (Mito) and S100. The levels of Mcl-1, Bcl-x L , and cytochrome c oxidase were determined in total cell lysate (lanes 1-4), S100 (lanes 5-8), and Mito (lanes 9-12). (B) Human fibroblast cells were treated (as described in Materials and Methods) with UV at different time points before harvest. Mcl-1, Bcl-x L , Bax, and cytochrome c levels were compared in the S100. Mcl-1, Bcl-x L , Bax, and cytochrome c oxidase were compared in the mitochondria.
Mcl-1, Bcl-x L , and Bax in the mitochondria and cytosol. Following UV treatment, both the disappearance of Mcl-1 and the translocation of Bax and Bcl-x L precede cytochrome c release (Fig. 3B ). These data demonstrate that following UV treatment the disappearance of Mcl-1 and translocation of Bcl-x L are not restricted to HeLa cells. Additionally, this experiment demonstrates that the translocation of Bax and Bcl-x L occurs with similar kinetics.
To determine if the disappearance of Mcl-1 is a general response to genotoxic stress, we analyzed the levels of Mcl-1 in cells treated with etoposide and ␥-irradiation. In both cases, Mcl-1 disappears from the cytosol and mitochondria well before cytochrome c is released and caspases are activated (Fig. 4A) . To evaluate the importance of the disappearance of Mcl-1 during UV-induced apoptosis, we used RNA interference (RNAi) to specifically knock down the levels of Mcl-1 ( Fig. 4B ; Elbashir et al. 2001) . The levels of Mcl-1 were decreased in cells transfected with Mcl-1 siRNA, whereas the levels of Bclx L remained unchanged (Fig. 4B , lane 5). When Mcl-1 was eliminated by siRNA treatment, UV-induced caspase-3 activation was accelerated, suggesting that the disappearance of Mcl-1 is an important early event in apoptosis (Fig. 4B, lower panel) . However, Mcl-1 siRNA-treated cells did not activate caspase-3 in the absence of UV, indicating that the elimination of Mcl-1 is not sufficient to activate caspase-3.
Mcl-1 elimination is caused by a lack of synthesis
UV-induced Mcl-1 elimination could be caused by accelerated protein degradation or inhibition of synthesis. To distinguish between these possibilities, we pulse-labeled cells with 35 S methionine and chased with or without UV irradiation. Newly synthesized Mcl-1 was analyzed by immunoprecipitation. As shown in Figure 5A and B, Mcl-1 is a short-lived protein with a half-life of ∼40 min. Interestingly, the half-life of Mcl-1 was the same with or without UV irradiation, even though the total amount of Mcl-1 protein was dramatically decreased after UV irradiation (Fig. 5A, lower panel) .
The above experiment suggests that Mcl-1 protein synthesis must be blocked after UV irradiation. To demonstrate that directly, we pulse-labeled the cells with 35 S methionine at the same time as UV irradiation (Fig. 5C , lanes 1,2). After a 60-min pulse, newly synthesized Mcl-1 was dramatically decreased if cells were exposed to UV irradiation. This decrease was not affected by blocking degradation with the proteasome inhibitor, MG132 (Fig. 5C , lanes 3,4; Palombella et al. 1994) . To verify that the disappearance of Mcl-1 protein is consis- tent with the inhibition of its synthesis, we treated HeLa cells with an inhibitor of protein synthesis, cycloheximide, and checked the fate of Mcl-1 protein in the same time course as UV irradiation. As shown in Figure 5D , Mcl-1 disappeared after UV or cycloheximide treatment at a similar rate.
Proteasome-mediated degradation of Mcl-1 is required for UV-induced apoptosis
The short half-life of Mcl-1 is due to constitutive polyubiquitination and subsequent degradation by the proteasome (data not shown). Hence, to test whether the elimination of Mcl-1 is necessary for apoptosis, we incubated UV-treated cells in the presence of MG132 or another structurally unrelated proteasome inhibitor, epoxomicin (Meng et al. 1999) . As shown in Figure 6A , both inhibitors efficiently block the degradation of Mcl-1 (Fig. 6A,  lanes 5-12) . Concomitantly, they also block other biochemical markers of apoptosis including Bcl-x L and Bax translocation, Bak oligomerization (data not shown), cytochrome c release, and caspase-3 activation.
To ensure that the antiapoptotic effect of the proteasome inhibitors was due specifically to the accumulation of Mcl-1, we first eliminated Mcl-1 using RNAi and then tested the effect of the proteasome inhibitors. As shown in Figure 6B , pretreatment of HeLa cells with Mcl-1 siRNA completely blocked the ability of MG132 or epoxomicin (data not shown) to prevent Bcl-x L and Bax translocation, cytochrome c release, and caspase-3 activation (Fig. 6B, lanes 4-6, and bar graph) . However, in control siRNA-treated cells, proteasome inhibitors efficiently blocked all of these events (Fig. 6B, lanes 1-3, and bar graph).
Mcl-1 is upstream of Bcl-x L and Bax translocation
The ability of proteasome inhibitors to block Bcl-x L /Bax translocation, Bak oligomerization, cytochrome c release, and caspase-3 activation indicates that proteasome-mediated degradation of Mcl-1 is an upstream step in this apoptotic pathway. This hypothesis predicts that if the levels of Mcl-1 are artificially elevated, downstream events such as Bax and Bcl-x L translocation will -8) . At the indicated times after treatment, the cells were harvested for S100 and mitochondria. The levels of Mcl-1 were determined by Western blotting both fractions. be delayed. We tested this hypothesis by developing two independent HeLa cell lines that stably express Flagtagged Mcl-1 under a CMV promoter. In response to UV irradiation, both the levels of endogenous Mcl-1 and the tagged Mcl-1 expressed from the transgene decreased (Fig. 7A, lanes 5-12) . Nevertheless, 4 h after UV irradiation, there was still some Flag-tagged Mcl-1 protein in the cytosol and mitochondria (Fig. 7A, lanes 8,12) . When the levels of Mcl-1 are artificially elevated in Mcl-1 transgenic cells, cytochrome c, Bcl-x L , and Bax do not translocate 4 h after UV irradiation in contrast to a control HeLa cell line that expresses the Neo vector (Fig. 7A,  lanes 1-4) , indicating that the elimination of Mcl-1 is a required upstream event for Bcl-x L and Bax translocation.
To verify that Mcl-1 degradation and Bax/Bcl-x L translocation are sequential events and not merely a product of antiapoptotic protein overexpression, we examined a Bcl-x L -overexpressing HeLa cell line, which also does not release cytochrome c after UV treatment (data not shown). After UV treatment, despite extremely high levels of exogenous Bcl-x L expression, Mcl-1 is eliminated at the same rate (Fig. 7B, lanes 4-6) . Moreover, in contrast to Mcl-1 overexpression, exogenous expression of Bcl-x L does not inhibit the translocation of Bax or Bcl-x L to the mitochondria (Fig. 7C, lanes 6-10) . Bcl-x L overexpression does, however, block the oligomerization of Bax on the mitochondria (Fig. 7C, bottom panel) suggesting the following sequence of events: Mcl-1 degradation, Bclx L /Bax translocation to the mitochondria, Bax oligomerization, and cytochrome c release.
Discussion
Mcl-1 and Bcl-x L function at different steps in a UV-induced apoptotic pathway
The Bcl-2 family is composed of both pro-and antiapoptotic proteins that share sequence and structural homology (Cory and Adams 2002) . Most of the initial studies of the Bcl-2 family used overexpression as a means of characterizing the apoptotic nature of the proteins (Vaux et 1,4) or UV-treated (lanes 2, 3, 5, 6) and harvested 4 h later. A small aliquot of the cell pellet was used to make whole cell lysate in 0.5% CHAPS for the caspase assay. The remaining cells were fractionated for mitochondria and S100. The levels of Mcl-1, Bcl-x L , Bax, and cytochrome c oxidase were measured in the mitochondria. The levels of Mcl-1, Bcl-x L , Bax, and cytochrome c were measured in the cytosol. al. 1988; Oltvai et al. 1993) . Although effective at separating pro-and antiapoptotic characteristics, overexpression studies do not differentiate specific functions within the pro-or antiapoptotic groups.
Mcl-1 removal required in UV apoptosis
Recently, genetic experiments separated the proapoptotic members of the Bcl-2 family into two functional classes: Bax/Bak and BH3-only proteins. BH3-only proteins are upstream of Bax/Bak because BH3-only proteins fail to trigger cytochrome c release in Bax/Bak-deficient cells Wei et al. 2001; Zong et al. 2001) . On the other hand, mouse knock'out models have proven less effective at sorting out the functions of the antiapoptotic Bcl-2 family members. Mcl-1-null embryos have a preimplantation lethal phenotype, revealing only that Mcl-1 has an important and early role in development (Rinkenberger et al. 2000) . The knockout of Bcl-x L was also early embryonic lethal; the embryo displayed widespread apoptosis, indicating that this gene also functions early in development (Motoyama et al. 1995) .
Using a biochemical approach, this study demonstrates that the antiapoptotic members of the Bcl-2 family also function at distinct steps. Mcl-1 is at the apical point in the pathway. The disappearance of Mcl-1 is required for downstream events including Bcl-x L and Bax translocation, Bak and Bax oligomerization, cytochrome c release, and caspase activation. Mcl-1 may regulate downstream events by sequestering proapoptotic BH3 proteins that activate downstream events such as Bax/ Bcl-x L translocation and Bax/Bak oligomerization (Letai et al. 2002) .
The cytosol-to-membrane translocation of both proapoptotic Bax and antiapoptotic Bcl-x L is counterintuitive and seemingly counterproductive. However, because the levels of Bax are in excess of Bcl-x L in HeLa cells (M. Fang and X. Wang, unpubl.) , continuous translocation of Bax may eventually result in excess free Bax on the mitochondria, leading to oligomerization. Consistent with this model, Bcl-x L overexpression blocks oligomerization but does not affect Bcl-x L or Bax translocation (Fig. 7C) . The effect of Bcl-2 overexpression on Bax translocation when apoptosis is induced by growth factor deprivation is variable. Bcl-2 overexpression blocks Bax translocation in B-cells after IL-3 withdrawal but not in primary neurons after NGF withdrawal (Gross et al. 1998; Putcha et al. 1999 ). 1-5) or Flag-Bcl-x L (lanes 6-10) were left untreated or UV-treated and harvested between 1 and 6 h later for mitochondria and S100. The levels of Flag-Bcl-x L , Bcl-x L , and Bax were determined in the S100 and mitochondria. Mitochondria were also used to evaluate Bax oligomerization.
Mcl-1 is an apical sensor for apoptotic stimuli
The elimination of Mcl-1 is not limited to UV irradiation. Genotoxic stress induced by etoposide or ␥-irradiation also efficiently induces Mcl-1 elimination (Fig. 4A) , suggesting that the disappearance of Mcl-1 may be initiated through a common pathway. Previous studies have shown that UV irradiation, ␥-irradiation, and etoposide treatment induce an arrest in protein synthesis (Clemens et al. 2000) . UV light treatment triggers the ubiquitination and subsequent degradation of RNA polymerase II and the GCN2-mediated phosphorylation of eIF2␣ to arrest transcription and translation, respectively (Bregman et al. 1996; Deng et al. 2002) . Because Mcl-1 protein and mRNA both have short half-lives (Yang et al. 1996) , Mcl-1 can serve as a sensor of acute changes in the rate of mRNA and protein synthesis after genotoxic stress. On the other hand, increased Mcl-1 synthesis may enhance the general well being of the cell. Growth factor pathways that promote cell survival through the AKT/ PI3 kinase pathway up-regulate Mcl-1 mRNA levels (Wang et al. 1999; Huang et al. 2000; Liu et al. 2001) . Our study predicts that this up-regulation of Mcl-1 may explain how growth factors render cells less sensitive to apoptotic stimuli (Datta et al. 1999) .
Although the elimination of Mcl-1 by an arrest in synthesis is required, this event is not sufficient for activation of the mitochondrial apoptosis pathway. The elimination of Mcl-1 by RNAi did not induce Bax/Bcl-x L translocation, Bax/Bak oligomerization (data not shown), cytochrome c release, and caspase activation (Figs. 4B,  6B) . Therefore, another UV-induced event in addition to the elimination of Mcl-1 must be required to promote this pathway. In other systems, it appears that Mcl-1 disappearance is both necessary and sufficient for apoptosis. For example, it is possible to induce apoptosis in a multiple myeloma cell line merely by treating it with inhibitors of protein synthesis or by specifically removing Mcl-1 with anti-sense oligonucleotides . In this system, depletion of Mcl-1 is the only hit needed for apoptosis.
Stress-activated pathways have also been implicated in UV-induced cytochrome c release. Fibroblasts deficient in JNK1/JNK2 kinases fail to release cytochrome c in response to UV treatment (Tournier et al. 2000) . JNK kinases might activate the Mcl-1 pathway by directly phosphorylating and inactivating Mcl-1 as they do after oxidative stress (Inoshita et al. 2002) . Alternatively, JNK activity might regulate pathways leading to a stop in Mcl-1 synthesis or initiate a separate required pathway. All of these possibilities can now be tested in JNK-deficient cells.
The quest to delineate the apoptosis pathway upstream of cytochrome c release is partly motivated by data suggesting that mitochondrial damage from proapoptotic Bcl-2 family members is toxic to cells even in the absence of caspase activation (Xiang et al. 1996) . Hence, potential therapies that inhibit apoptosis before the onset of mitochondrial dysfunction are likely to be more effective than direct caspase inhibitors. The sequential nature of the apoptotic signal transduction pathway revealed by this study offers several points for potential intervention. Novel therapies that block Mcl-1 degradation may effectively prevent apoptosis and cell death.
Materials and methods
Reagents
The following antibodies were used for Western blots: monoclonal Bak Ab-1 (Oncogene), monoclonal cytochrome c (Pharmingen), polyclonal Bcl-x L (Cell signaling), monoclonal Mcl-1 (Pharmingen), monoclonal caspase-2 (Pharmingen), polyclonal caspase-3 (cell signaling), monoclonal caspase-9 (Cell Signaling), and polyclonal Bax N-20 (Santa Cruz). Immunoprecipitations or immunodepletions for Mcl-1 and Bcl-x L were performed with polyclonal antibodies to Mcl-1 (Pharmingen) and Bcl-x L (Cell Signaling). Z-VAD.fmk, cycloheximide, MG132, epoxomicin, caspase-3 fluorogenic II substrate, phosphatase inhibitor cocktail II, and Protein Phosphatase were all obtained from Calbiochem.
UV treatment and cellular fractionation
HeLa cells were plated at a density of 2 × 10 7 cells in a 15-cm dish with DMEM medium supplemented with 10% FBS. Several hours before treatment, each dish was replaced with 13 mL of fresh medium. The cover of each dish was removed before the cells were treated in a Stratagene stratalinker with 200 mJ/cm 2 of UV irradiation (254 nm). At the indicated times after treatment, cells were scraped, collected, and washed once in PBS. The cell pellet was resuspended in 5 times the volume of Buffer A (20 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, and Complete Protease Inhibitor; Roche) supplemented with 250 mM sucrose. The resuspended cell pellet was incubated on ice for 15 min before the cells were broken by passing them through a 22-gauge needle 25 times. The resulting broken cell mixture was centrifuged in three sequential steps: 1000g, 10,000g, and 100,000g. The 10,000g pellet was considered the "mitochondrial" fraction and the 100,000g supernatant (S100) the cytosol. Mitochondrial pellets were lysed in SDS loading buffer, and equal volumes were analyzed by SDS-PAGE. S100 protein concentrations were normalized using the Bio-Rad Bradford reagent.
Recombinant Mcl-1 and Bcl-x L
The cDNA of full-length human Mcl-1 was subcloned into NdeI and SapI sites of the pTYB1 vector (New England Biolabs). Fulllength Bcl-x L cDNA was cloned into NdeI and XhoI sites of the pet15B vector (Novagen). BL21 (DE3) cells were transformed with these constructs, and the recombinant proteins were purified according to the manufacturer's protocol (New England Biolabs and QIAGEN, respectively). The eluted recombinant Mcl-1 protein was purified in two additional steps: Hitrap Q sepharose and Superdex 200 size exclusion chromatography. The eluted recombinant Bcl-x L was further purified on a Hitrap Q sepharose column.
In vitro assays for mitochondrial priming and inhibitory activity
Mitochondria (0.67 mg/mL) alone or with S100 (4 mg/mL) were incubated in Buffer A with 250 mM sucrose and 150 mM NaCl
Mcl-1 removal required in UV apoptosis at 37°C for 15 min. Following incubation, the mitochondria were pelleted, and the supernatant was tested for cytochrome c release. The mitochondria pellet was tested for Bak oligomerization .
During biochemical fractionation, to increase our yield we made S100 from HeLa cells using Buffer A without sucrose. Hypotonic buffers cause mitochondrial rupture and cytochrome c contamination in the S100. Contaminating cytochrome c was removed from the S100 by incubating with SP-sepharose XL resin (Amersham) at 4°C for 1 h. Cytochrome c binds SP resin, but our activity does not (data not shown).
Mcl-1 RNA interference
Annealed, purified, and desalted double-stranded siRNA, Luciferase (AACGUACGCGGAAUACUUCGA), and Mcl-1 (AAGAAACGCGGUAAUCGGACU) were ordered from Dharmacon Research. Then 1.5 × 10 5 HeLa cells were plated in a 6-well dish on day 0. On day 1, cells were transfected with 200 nM siRNA in Opti-MEM medium (Invitrogen) without FBS using Oligofectamine reagent (Invitrogen) according to the manufacturer's transfection protocol. After 4 h, FBS was added to a final concentration of 10%. On day 2, the medium over the cells was adjusted to 1 mL before treatment.
Fluorogenic assay for caspase-3 activity
In a 20-µL system, 10 µg of whole cell lysate was incubated in Buffer A containing 0.125% CHAPS and 10 µM fluorogenic DEVD substrate. Samples were applied to a 384-well microplate, and the reaction was carried out at 30°C. Every 10 min, the samples were excited at 360 nM and the OD 465 nM was measured by the SpectraFluor4 spectrometry reader (TECAN).
Mcl-1 pulse-chase experiments
HeLa suspension cells were plated at a density of 5 × 10 6 cells per 10-cm dish. For the pulse chase, the cells were washed with phosphate-buffered saline (PBS), starved in methionine/cysteine-free DMEM (GIBCO-BRL) at 37°C for 30 min, then labeled with 200-500 µCi of [ 35 S]cysteine/methionine (ICN) per plate at 37°C for 60 min. After labeling, the cells were chased with complete DMEM containing 10% FBS and 2 M cold methionine at 37°C for the indicated amount of time. A total of 10 7 cells were collected at each time point. Cells were subsequently subjected to immunoprecipitation analysis as described below.
Immunoprecipitation
For immunodepletion and Mcl-1 immunoprecipitation experiments, samples were incubated with beads precoupled to antibody. Protein A agarose beads (Santa Cruz; 0.5-mL bed volume) were incubated in 1 mL of PBS with 1 mg/mL of BSA at 4°C alone overnight, with 100 µg of polyclonal antibodies to Mcl-1 or Bcl-x L . After incubation, the beads were pelleted by centrifugation and washed at least 5 times with Buffer A. For immunodepletion reactions, 50 µL of beads were incubated with 500 µL of S100 (5 mg/mL) with rotation at 4°C overnight. After incubation, the beads were pelleted, and the supernatant was collected as immunodepleted S100.
For pulse-chase experiments, radiolabeled cells were lysed in cold RIPA lysis buffer (10 mM Tris-HCl at pH 7.4, 1% NP-40, 1 mM EDTA, 0.1% SDS, 150 mM NaCl) with fresh proteinase inhibitors, followed by breaking through a 25-gauge syringe 20 times. Equivalent amounts of cell extract were adjusted to equal volumes with RIPA buffer, precleared with protein A agarose beads, and clarified by centrifugation. Lysates were then incubated with polyclonal antibodies to Mcl-1 at 4°C overnight, and the immune complexes were precipitated with protein A agarose beads for 4-6 h. The immunoprecipitates were washed five times with RIPA buffer and incubated at 95°C for 5 min in SDS sample buffer. Samples were subjected to (SDS-PAGE) followed by autoradiography.
Mcl-1-and Bcl-x L -overexpressing stable cell lines
Full-length Mcl-1 cDNA was cloned into HindIII and BamHI sites of p3XFLAG-CMV-10 (Sigma). The resulting fusion protein was full-length Mcl-1 with three Flag epitopes at the N terminus followed by a two-amino-acid linker. The full-length Bcl-x L was cloned into XhoI and NdeI sites of pCDNA 3.1(−) (Invitrogen) with a single Flag tag at the N terminus followed by a short linker sequence. Empty vector or subcloned plasmids were transfected into 5 × 10 5 attached HeLa cells grown in DMEM with 10% FBS using Lipofectamine Plus transfection reagent (Invitrogen) according to the manufacturer's protocol. Then, 2 d later, the cells were transferred to 20 100-mm dishes in DMEM with 10% FBS and 0.5 mg/mL of G418. After several weeks, individual clones were lifted and tested for expression of the transgene.
